FDA-Drug2022-06-22Class II
medroxyPROGESTERone Acetate Injectable Suspension, USP, 25 x 1 mL Single-Dose Vial, 150 mg/mL, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Halol Baroda Highway, Halol-389 350, Gujarat India , NDC 16714-090-40 packaged in 25 count carton.
Hazard
Lack of assurance of sterility
Sold states
USA Nationwide
Affected count
26892 vials
Manufactured in
2 Independence Way, Princeton, NJ, United States
Products
medroxyPROGESTERone Acetate Injectable Suspension, USP, 25 x 1 mL Single-Dose Vial, 150 mg/mL, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Halol Baroda Highway, Halol-389 350, Gujarat India , NDC 16714-090-40 packaged in 25 count carton.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1147-2022More SUN PHARMACEUTICAL INDUSTRIES INC recalls
- FDA-Drug2026-06-17Sun Pharmaceutical budesonide inhalation suspension recalled for foreign particles
- FDA-Drug2026-06-17Sun Pharmaceutical doxorubicin injection recalled for glass particles
- FDA-Drug2026-04-22Taro Fluocinonide 0.05% Cream recalled for failed viscosity specifications
- FDA-Drug2026-04-22Taro Pharmaceuticals fluocinonide cream recalled for failed viscosity specifications
- FDA-Drug2026-04-22Taro Pharmaceuticals fluocinonide 0.05% cream recalled for viscosity defect
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief